Commodities
Cytek Biosciences Patent Victory: What Three of Four Wins Mean for CYTK Stock and Biotech Investors
Cytek Biosciences has secured a favorable ruling on three of four patent claims, a partial but meaningful legal win that reshapes competitive dynamics in the full-spectrum flow cytometry market. Here is what it means for CYTK's valuation, the broader life-sciences instruments sector, and how traders should frame their risk.